101 related articles for article (PubMed ID: 23740063)
1. Autoantibody profile in individuals with chronic hepatitis C.
Marconcini ML; Fayad L; Shiozawa MB; Dantas-Correa EB; Lucca Schiavon Ld; Narciso-Schiavon JL
Rev Soc Bras Med Trop; 2013; 46(2):147-53. PubMed ID: 23740063
[TBL] [Abstract][Full Text] [Related]
2. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
3. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.
Muratori P; Muratori L; Guidi M; Granito A; Susca M; Lenzi M; Bianchi FB
Clin Infect Dis; 2005 Feb; 40(4):501-7. PubMed ID: 15712070
[TBL] [Abstract][Full Text] [Related]
4. [Detection and the production mechanism of antinuclear antibodies (ANA) and anti-liver/kidney microsomal tpe 1 antibodies (anti-LKM1) in patients with chronic hepatitis C].
Bai L; Lu HY; Feng ZR; Yu M; Li WG; Gong WB; Zhao NE; Xu XY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):278-81. PubMed ID: 20108773
[TBL] [Abstract][Full Text] [Related]
5. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile.
Cassani F; Cataleta M; Valentini P; Muratori P; Giostra F; Francesconi R; Muratori L; Lenzi M; Bianchi G; Zauli D; Bianchi FB
Hepatology; 1997 Sep; 26(3):561-6. PubMed ID: 9303483
[TBL] [Abstract][Full Text] [Related]
6. Non-organ-specific autoantibodies in chronic hepatitis C patients: association with histological activity and fibrosis.
Chrétien P; Chousterman M; Abd Alsamad I; Ozenne V; Rosa I; Barrault C; Lons T; Hagège H
J Autoimmun; 2009; 32(3-4):201-5. PubMed ID: 19324518
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of autoantibody and its relationship with genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection.
Kirdar S; Sener AG; Cengİz M; Aydin N
APMIS; 2016 Nov; 124(11):979-984. PubMed ID: 27670736
[TBL] [Abstract][Full Text] [Related]
9. [Autoantibodies in chronic hepatitis C. Markers of autoimmunity or non-specific events?].
Vella FS; Orlando P; Attanasi F; Simone B; Mundo A; Lopalco P; Schiraldi O; Antonaci S
Recenti Prog Med; 2001 Feb; 92(2):107-12. PubMed ID: 11294098
[TBL] [Abstract][Full Text] [Related]
10. Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey.
Stroffolini T; Colloredo G; Gaeta GB; Sonzogni A; Angeletti S; Marignani M; Pasquale G; Venezia G; Craxì A; Almasio P
J Viral Hepat; 2004 May; 11(3):257-62. PubMed ID: 15117328
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in chronic hepatitis C virus infection and their association with disease profile.
Williams MJ; Lawson A; Neal KR; Ryder SD; Irving WL;
J Viral Hepat; 2009 May; 16(5):325-31. PubMed ID: 19302340
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort.
Lenzi M; Bellentani S; Saccoccio G; Muratori P; Masutti F; Muratori L; Cassani F; Bianchi FB; Tiribelli C
Gut; 1999 Sep; 45(3):435-41. PubMed ID: 10446115
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
Bai L; Feng ZR; Lu HY; Li WG; Yu M; Xu XY
Chin Med J (Engl); 2009 Jan; 122(1):5-9. PubMed ID: 19187609
[TBL] [Abstract][Full Text] [Related]
14. Non-organ-specific autoantibodies in children with chronic hepatitis C: clinical significance and impact on interferon treatment.
Muratori P; Muratori L; Verucchi G; Attard L; Bianchi FB; Lenzi M
Clin Infect Dis; 2003 Nov; 37(10):1320-6. PubMed ID: 14583865
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of GBV-C/HGV-RNA, virus genotypes, and anti-E2 antibodies in autoimmune hepatitis.
Tribl B; Schöniger-Hekele M; Petermann D; Bakos S; Penner E; Müller C
Am J Gastroenterol; 1999 Nov; 94(11):3336-40. PubMed ID: 10566740
[TBL] [Abstract][Full Text] [Related]
16. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.
Indolfi G; Stagi S; Bartolini E; Salti R; de Martino M; Azzari C; Resti M
Clin Endocrinol (Oxf); 2008 Jan; 68(1):117-21. PubMed ID: 17692107
[TBL] [Abstract][Full Text] [Related]
17. The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C.
Wasmuth HE; Stolte C; Geier A; Dietrich CG; Gartung C; Lorenzen J; Matern S; Lammert F
BMC Infect Dis; 2004 Feb; 4():4. PubMed ID: 15040810
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility to thyroid disorders in hepatitis C.
Muratori L; Bogdanos DP; Muratori P; Lenzi M; Granito A; Ma Y; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Gastroenterol Hepatol; 2005 Jun; 3(6):595-603. PubMed ID: 15952102
[TBL] [Abstract][Full Text] [Related]
19. Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection.
Ruggeri C; La Masa AT; Rudi S; Squadrito G; Di Pasquale G; Maimone S; Caccamo G; Pellegrino S; Raimondo G; Magazzù G
Dig Dis Sci; 2008 Aug; 53(8):2151-5. PubMed ID: 18231858
[TBL] [Abstract][Full Text] [Related]
20. Serological markers of autoimmunity in renal transplant patients with chronic hepatitis C.
Rostaing L; Modesto A; Cisterne JM; Izopet J; Oksman F; Duffaut M; Abbal M; Durand D
Am J Nephrol; 1998; 18(1):50-6. PubMed ID: 9481439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
